Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program

PloS One
André Mario DoiArnaldo Lopes Colombo

Abstract

Candidemia is a growing problem in hospitals all over the world. Despite advances in the medical support of critically ill patients, candidiasis leads to prolonged hospitalization, and has a crude mortality rate around 50%. We conducted a multicenter surveillance study in 16 hospitals distributed across five regions of Brazil to assess the incidence, species distribution, antifungal susceptibility, and risk factors for bloodstream infections due to Candida species. From June 2007 to March 2010, we studied a total of 2,563 nosocomial bloodstream infection (nBSI) episodes. Candida spp. was the 7th most prevalent agent. Most of the patients were male, with a median age of 56 years. A total of 64 patients (46.7%) were in the ICU when candidemia occurred. Malignancies were the most common underlying condition (32%). The crude mortality rate of candidemia during the hospital admission was 72.2%. Non-albicans species of Candida accounted for 65.7% of the 137 yeast isolates. C. albicans (34.3%), Candida parapsilosis (24.1%), Candida tropicalis (15.3%) and Candida glabrata (10.2%) were the most prevalent species. Only 47 out of 137 Candida isolates were sent to the reference laboratory for antifungal susceptibility testing. All C. albic...Continue Reading

References

Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Abi-SaidS Vartivarian
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Aug 8, 2006·Journal of Clinical Microbiology·Arnaldo L ColomboUNKNOWN Brazilian Network Candidemia Study
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Manuel Cuenca-EstrellaJuan L Rodriguez-Tudela
Jul 28, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marcio NucciArnaldo L Colombo
Mar 18, 2011·Journal of Clinical Microbiology·Alexandre R MarraUNKNOWN Brazilian SCOPE Study Group
Jul 6, 2012·Medical Mycology·Arnaldo L ColomboMarcio Nucci
Oct 16, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Pao-Yu ChenYee-Chun Chen
Mar 26, 2013·PloS One·Marcio NucciUNKNOWN Latin American Invasive Mycosis Network
Jun 15, 2013·Revista iberoamericana de micología·Marcio NucciUNKNOWN Latin America Invasive Mycosis Network
Jun 20, 2013·Memórias do Instituto Oswaldo Cruz·Marcos Paulo WilleArnaldo Lopes Colombo
Oct 26, 2013·Virulence·Julie Delaloye, Thierry Calandra
Nov 5, 2013·International Journal of Antimicrobial Agents·Hilmar WisplinghoffHarald Seifert
Dec 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ChowdharyJ F Meis
Jan 29, 2014·Antimicrobial Agents and Chemotherapy·Fernando César BizerraArnaldo L Colombo
Mar 29, 2014·The New England Journal of Medicine·Shelley S MagillUNKNOWN Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team
May 9, 2014·Intensive Care Medicine·Matteo BassettiMario Tumbarello
Aug 7, 2014·Intensive Care Medicine·Olivier LortholaryUNKNOWN French Mycosis Study Group
Aug 19, 2014·International Journal of Antimicrobial Agents·Mariana CastanheiraMichael A Pfaller
Oct 12, 2014·Current Opinion in Infectious Diseases·Maiken C Arendrup, David S Perlin
Oct 16, 2014·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Armin AhmedMohan Gurjar
Aug 12, 2015·Antimicrobial Agents and Chemotherapy·Ana Carolina R SouzaArnaldo L Colombo
Oct 9, 2015·The New England Journal of Medicine·Bart Jan Kullberg, Maiken C Arendrup

❮ Previous
Next ❯

Citations

Feb 12, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E Alvarez Duarte, D W Denning
Mar 31, 2017·Infectious Diseases and Therapy·Diego R FalciAlessandro C Pasqualotto
Mar 14, 2017·Microbiological Research·Yiqing Tong, Jianguo Tang
Feb 2, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Fernández-RuizUNKNOWN GEIH-GEMICOMED (SEIMC) and REIPI
Apr 10, 2018·Journal of Intensive Care Medicine·Hasan M Al-DorziYaseen M Arabi
Nov 8, 2017·Future Microbiology·Eliane M da SilvaTerezinha Ie Svidzinski
Dec 22, 2017·BMC Infectious Diseases·Eliane Martins da SilvaTerezinha Inez Estivalet Svidzinski
Jan 18, 2018·Folia Microbiologica·Márcia C FurlanetoLuciana Furlaneto-Maia
Mar 9, 2019·PloS One·Maria E SantolayaUNKNOWN Chilean Invasive Mycosis Network
Apr 20, 2018·BMC Infectious Diseases·Tatiana Aporta MarinsMarcelino Souza Durão Junior
May 12, 2018·Nature Reviews. Disease Primers·Peter G PappasBart Jan Kullberg
Aug 23, 2019·PloS One·Mariana Araújo Paulo de MedeirosGuilherme Maranhão Chaves
Jan 6, 2018·The Journal of Antimicrobial Chemotherapy·Frederic LamothThierry Calandra
Mar 9, 2018·FEMS Yeast Research·Tânia Raquel Rodrigues GrainhaAnália Maria Garcia Lourenço
Oct 12, 2019·Molecular Biology Reports·Carolina do Rosário Esteves GuimarãesTânia Fraga Barros
Jan 15, 2020·PloS One·Daniella Renata FariaErika Seki Kioshima
Oct 28, 2019·Current Topics in Medicinal Chemistry·Laura Nunes SilvaAndré Luis Souza Dos Santos
Sep 20, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Riad KhatibLeonard B Johnson
Sep 26, 2020·Natural Product Research·Daniele de Figueredo SilvaEdeltrudes de Oliveira Lima
Mar 11, 2020·International Journal of Molecular Sciences·Daniele SilvaEdeltrudes Lima
May 21, 2016·Journal of Clinical Pharmacology·Maria Clara Padovani de SouzaAdriano Max Moreira Reis
Dec 17, 2016·Emerging Infectious Diseases·Sara StrolloD Rebecca Prevots
May 13, 2019·Antonie van Leeuwenhoek·Josidel Conceição OliverAmanda Latercia Tranches Dias
Mar 1, 2019·Clinical Microbiology Reviews·Renáta TóthAttila Gácser
Jun 9, 2020·Frontiers in Microbiology·Orawan TulyaprawatPopchai Ngamskulrungroj
Aug 29, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Thaísa Cristina SilvaMaria do Rosário Rodrigues Silva
Oct 31, 2017·Frontiers in Microbiology·Diana L Zuza-AlvesGuilherme M Chaves
May 11, 2018·Journal of General and Family Medicine·Minoru MurakamiMasaya Ikezoe
Jul 2, 2019·Frontiers in Microbiology·Linh Thi Truc PhamPopchai Ngamskulrungroj
May 10, 2019·Open Forum Infectious Diseases·Maiken Cavling ArendrupMarie Helleberg
Feb 24, 2019·Journal of Fungi·Jehoshua SharmaRebecca S Shapiro
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva
Jun 20, 2016·Mycopathologia·Francieli ChassotSydney Hartz Alves
Jan 27, 2018·Journal of Fungi·Harsimran Kaur, Arunaloke Chakrabarti

❮ Previous
Next ❯

Software Mentioned

SPSS
Biotyper

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.